Naphthoquinone

Naphthoquinone

SCHEMBL1234009

C1=CCOC=C1.O=C1C=CC(=O)c2ccccc21

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 5/20 0.52
IDO1 P14902 3/20 0.52
PIN1 Q13526 2/20 0.52
MAOA P21397 2/20 0.52
MAOB P27338 2/20 0.52
AKT1 P31749 1/20 0.52
SNCA P37840 1/20 0.52
MAP2K1 Q02750 1/20 0.52
EHMT2 Q96KQ7 1/20 0.52
NSD1 Q96L73 1/20 0.52
EHMT1 Q9H9B1 1/20 0.52
ALOX15 P16050 3/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
THRB P10828 2/20 0.34
HPGD P15428 2/20 0.34
RECQL P46063 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28135562 0.81 S100A4 (0.35) CDC25BMAOAMAOBALOX15MEN1
SCHEMBL7602072 0.77 KMT2A (0.35) MEN1KMT2AKDM4EALDH1A1MAPT
Triphenylene SCHEMBL5429154 0.76 KDM4E (0.30) MAOAKDM4EALDH1A1MAPTHPGD
Naphthoquinone SCHEMBL27677906 0.76 CDC25B (0.67) CDC25BIDO1PIN1MAOAMAOB
Naphthalene SCHEMBL27561595 0.76 CYP2A6 (0.38)
Biphenyl SCHEMBL27460490 0.74 ALDH1A1 (0.41) ALDH1A1HSD17B10TDP1TP53CYP3A4
Benzoquinone SCHEMBL27507434 0.74 ALDH1A1 (0.36) MAOAMAOBALDH1A1RECQLHSD17B10
SCHEMBL6771389 0.73 NISCH (0.37) MAOAMAOBALOX15KDM4EALDH1A1
SCHEMBL28530787 0.72 ALOX15 (0.43) ALOX15MEN1KMT2AALDH1A1MAPT
Benzene SCHEMBL27406391 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116410173-B Pyran naphthoquinone compound, preparation method, composition and application thereof 兰州大学 2024-06-11 CN claimed
CN-117567424-A Method for preparing sulfur-containing pyran naphthoquinone compound by co-culture of streptomycete-bacillus and application of sulfur-containing pyran naphthoquinone compound 南京中医药大学 2024-02-20 CN claimed
CN-116410173-A Pyran naphthoquinone compound, preparation method, composition and application thereof 兰州大学 2023-07-11 CN claimed
US-20180055816-A1 PYRANONAPHTHOQUINONE COMPOUNDS AND METHODS OF USE THEREOF UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2018-03-01 US claimed
JP-63277680-A None JP disclosed
US-12037342-B2 Substituted eneoxindoles and uses thereof GILEAD SCIENCES, INC. (US) 2024-07-16 US disclosed
CN-118355020-A Therapeutic compounds for HIV virus infection 吉利德科学公司 2024-07-16 CN disclosed
CN-118324767-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-07-12 CN disclosed
US-20240226130-A1 4'-THIONUCLEOSIDE ANALOGUES AND THEIR PHARMACEUTICAL USE GILEAD SCIENCES, INC. 2024-07-11 US disclosed
EP-4310087-B1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES INC (US) 2024-07-03 EP disclosed
US-12024528-B2 Bridged tricyclic carbamoylpyridone compounds and uses thereof GILEAD SCIENCES, INC. (US) 2024-07-02 US disclosed
WO-2024137852-A1 PRMT5 INHIBITORS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2024-06-27 WO disclosed
EP-2137168-A1 NOVEL IDO INHIBITORS AND METHODS OF USE THEREOF Lankenau Institute for Medical Research (US) 2009-12-30 EP disclosed
WO-2008115804-A1 NOVEL IDO INHIBITORS AND METHODS OF USE THEREOF LANKENAU INSTITUTE FOR MEDICAL RESEARCH (US) 2008-09-25 WO disclosed
EP-1650209-A1 Griseusin derivatives and their use as antitumor agents Oncotest GmbH (DE) 2006-04-26 EP disclosed
US-5736523-A ADMINISTERING TO THE MAMMAL SUFFERING FROM CANCER BIOCHEM PHARMA INC. (CA) 1998-04-07 US disclosed
US-5606037-A Processes antineoplastic heteronaphthoquinones BIOCHEM PHARMA INC. (CA) 1997-02-25 US disclosed
EP-0659190-A1 ANTINEOPLASTIC HETERONAPHTHOQUINONES BIOCHEM PHARMA INC (CA) 1995-06-28 EP disclosed
WO-1994011382-A1 ANTINEOPLASTIC HETERONAPHTHOQUINONES BIOCHEM PHARMA INC. (CA) 1994-05-26 WO disclosed
JP-S63277680-A PORPHYRIN COMPOUND, ITS PRODUCTION AND FLUORESCENT COLOR-DEVELOPING AGENT CONTAINING SAID COMPOUND NIPPON OIL & FATS CO LTD 1988-11-15 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240226130-A1 4'-THIONUCLEOSIDE ANALOGUES AND THEIR PHARMACEUTICAL USE TYMP, MTAP, TPMT CDC25B 2392/4885IDO1 2551/4885PIN1 2343/4885
US-12037342-B2 Substituted eneoxindoles and uses thereof HIPK1, HPGDS, HIPK3 CDC25B 1388/4885IDO1 329/4885PIN1 1769/4885
US-12024528-B2 Bridged tricyclic carbamoylpyridone compounds and uses thereof SDHA, SDHB, DPYD CDC25B 727/4885IDO1 1734/4885PIN1 998/4885
US-20180055816-A1 PYRANONAPHTHOQUINONE COMPOUNDS AND METHODS OF USE THEREOF EIF4EBP1, EIF4E, MTOR CDC25B 495/4885IDO1 4639/4885PIN1 1555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.